The Food and Drug Administration (FDA) has published a discussion paper on communicating cybersecurity vulnerabilities to patients, in preparation for the October 2020 meeting of the Patient Engagement Advisory Committee of the FDA’s Center for Devices and Radiologic Health. The FDA has recognized that cybersecurity risks pose significant patient safety concerns for connected medical devices. The term “connected medical devices” includes medical devices that are connected to the internet, to hospital networks, or to other medical devices. Examples are sensor-based technologies such as wearables, to implantable medical devices such as pacemakers.
- Published: 27 October 2020 27 October 2020
- CMS delays rule on covering breakthrough devices until December 15, 2021
- Doximity files registration statement for IPO
- FDA to issue leapfrog guidance on brain-computer interface devices
- HHS launches public-private venture capital partnership
- ONC publishes Health IT Standards Bulletin addressing race and ethnicity